About Us Harmattan AI is a next-generation defense prime building autonomous and scalable defense systems. Following the close of a $200M Series B, valuing the company at $1.4 billion, we are expanding our teams and capabilities
Bioptimus is building the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovation in biomedicine. With more than $75M in funding, Bioptimus is a fast-growing start-up headquartered in Paris, incorporated in
Job title: Scientific Data Analyst Location: France, Marcy letoile Job type : CDI Permanent Contract About the job As Scientific Data Analyst within our Vaccines Biostatistical Sciences team, you have a passion to leverage your programming and AI/ML
About Us Harmattan AI is a next-generation defense prime building autonomous and scalable defense systems. Following the close of a $200M Series B, valuing the company at $1.4 billion, we are expanding our teams and capabilities
Beacon Biosignals is transforming precision medicine for the brain, from clinical development to clinical care. For Life Sciences partners, we offer the leading at-home EEG platform for clinical development of novel therapeutics for neurological, psychiatric, and
Beacon Biosignals is transforming precision medicine for the brain, from clinical development to clinical care. For Life Sciences partners, we offer the leading at-home EEG platform for clinical development of novel therapeutics for neurological, psychiatric, and
Consultant(e) Expert(e) Dataiku Lieu : Paris / Île-de-France – Hybride Type : CDI / Mission longue durée Secteur : ESN – Client grands comptes Le contexte : Rejoignez un projet Data innovant pour l’un de nos clients
At Ayvens, progress starts with you. Our ambitions to shape the future of sustainable mobility are powered by our talent. Join us, and get better with every move. At Ayvens, progress starts with you. Our ambitions
About Us Harmattan AI is a next-generation defense prime building autonomous and scalable defense systems. Following the close of a $200M Series B, valuing the company at $1.4 billion, we are expanding our teams and capabilities
Lead Data Scientist Localisation : Paris, France LexisNexis Risk Solutions est un leader mondial dans le domaine de la technologie et de l’analyse de données, s’attaquant à certains des défis les plus complexes et les plus significatifs
Job description in French (English version at the bottom) Lead Data Scientist Localisation : Paris, France LexisNexis Risk Solutions est un leader mondial dans le domaine de la technologie et de l’analyse de données, s’attaquant à certains
# Lead Data ScientistApplylocations: Paristime type: Full timeposted on: Posted Todayjob requisition id: R Job description in French (English version at the bottom) Lead Data Scientist Localisation : Paris, France LexisNexis Risk Solutions est un leader mondial dans
Harmattan AI is seeking a Data Engineer in Paris to own the data layer feeding ML models, from raw logs to curated, versioned datasets. You will build training-ready datasets, manage terabytes of unstructured data, and enable modelers to focus
Synchrone recrute un Expert Dataiku pour concevoir et optimiser les workflows et modèles prédictifs sur Dataiku DSS. Vous piloterez des pipelines complexes, intègrerez bases et API, et collaborerez avec les équipes métiers et techniques pour livrer
Job Title: Enterprise Senior Principal Lead Full‑Stack Omni‑Channel Cloud Architect, Developer, & Quality Assurance Visionary (GenAI/Web5/Quantum‑Ready) – Level IX (Band 12‑A) Job Code: HEX:0x7F_OCT:0177_BIN: Compensation: $1.00 – $9,999,999,999.99 / annum + % Trinitrotoluene Stock Options (Subject
This position is listed on behalf of a partner company, who manages all applications and next steps. Our partner is looking for an AI/ML Engineer based in France. This is an opportunity to develop AI and
Beacon Biosignals is transforming precision medicine for the brain, from clinical development to clinical care. For Life Sciences partners, we offer the leading at-home EEG platform for clinical development of novel therapeutics for neurological, psychiatric, and